Antiarrhythmic Drugs [electronic resource] : Mechanisms of Antiarrhythmic and Proarrhythmic Actions /

Management and prevention of tachyarrhythmias, especially of serious ventricular arrhythmias after myocardial infarction, is still a major problem. Large-scale evidence suggests an increased harm induced by antiarrhythmic drugs in the presence of organic heart disease although they effectively suppress spontaneous arrhythmias. This increased risk has been linked to their proarrhythmic potential and to possible interactions by ischaemia. However, the mechanisms by which antiarrhythmic drugs exert their antiarrhythmic and proarrhythmic actions are still poorly understood. Therefore, it was a time to present an update on the mechanisms of antiarrhythmic and proarrhythmic action of drugs which act on the electrophysiological properties of the heart. World renowned electrophysiologists as well as clinicians have joint to address important topics which range from the effect of antiarrhythmic drugs on single channels and on arrhythmia models to the clinical arena.

Saved in:
Bibliographic Details
Main Authors: Breithardt, Günter. editor., Borggrefe, Martin. editor., Camm, A. John. editor., Shenasa, Mohammad. editor., Haverkamp, Wilhelm. editor., Hindricks, Gerhard. editor., SpringerLink (Online service)
Format: Texto biblioteca
Language:eng
Published: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 1995
Subjects:Medicine., Pharmacology., Cardiology., Medicine & Public Health., Pharmacology/Toxicology.,
Online Access:http://dx.doi.org/10.1007/978-3-642-85624-2
Tags: Add Tag
No Tags, Be the first to tag this record!
id KOHA-OAI-TEST:231226
record_format koha
institution COLPOS
collection Koha
country México
countrycode MX
component Bibliográfico
access En linea
En linea
databasecode cat-colpos
tag biblioteca
region America del Norte
libraryname Departamento de documentación y biblioteca de COLPOS
language eng
topic Medicine.
Pharmacology.
Cardiology.
Medicine & Public Health.
Cardiology.
Pharmacology/Toxicology.
Medicine.
Pharmacology.
Cardiology.
Medicine & Public Health.
Cardiology.
Pharmacology/Toxicology.
spellingShingle Medicine.
Pharmacology.
Cardiology.
Medicine & Public Health.
Cardiology.
Pharmacology/Toxicology.
Medicine.
Pharmacology.
Cardiology.
Medicine & Public Health.
Cardiology.
Pharmacology/Toxicology.
Breithardt, Günter. editor.
Borggrefe, Martin. editor.
Camm, A. John. editor.
Shenasa, Mohammad. editor.
Haverkamp, Wilhelm. editor.
Hindricks, Gerhard. editor.
SpringerLink (Online service)
Antiarrhythmic Drugs [electronic resource] : Mechanisms of Antiarrhythmic and Proarrhythmic Actions /
description Management and prevention of tachyarrhythmias, especially of serious ventricular arrhythmias after myocardial infarction, is still a major problem. Large-scale evidence suggests an increased harm induced by antiarrhythmic drugs in the presence of organic heart disease although they effectively suppress spontaneous arrhythmias. This increased risk has been linked to their proarrhythmic potential and to possible interactions by ischaemia. However, the mechanisms by which antiarrhythmic drugs exert their antiarrhythmic and proarrhythmic actions are still poorly understood. Therefore, it was a time to present an update on the mechanisms of antiarrhythmic and proarrhythmic action of drugs which act on the electrophysiological properties of the heart. World renowned electrophysiologists as well as clinicians have joint to address important topics which range from the effect of antiarrhythmic drugs on single channels and on arrhythmia models to the clinical arena.
format Texto
topic_facet Medicine.
Pharmacology.
Cardiology.
Medicine & Public Health.
Cardiology.
Pharmacology/Toxicology.
author Breithardt, Günter. editor.
Borggrefe, Martin. editor.
Camm, A. John. editor.
Shenasa, Mohammad. editor.
Haverkamp, Wilhelm. editor.
Hindricks, Gerhard. editor.
SpringerLink (Online service)
author_facet Breithardt, Günter. editor.
Borggrefe, Martin. editor.
Camm, A. John. editor.
Shenasa, Mohammad. editor.
Haverkamp, Wilhelm. editor.
Hindricks, Gerhard. editor.
SpringerLink (Online service)
author_sort Breithardt, Günter. editor.
title Antiarrhythmic Drugs [electronic resource] : Mechanisms of Antiarrhythmic and Proarrhythmic Actions /
title_short Antiarrhythmic Drugs [electronic resource] : Mechanisms of Antiarrhythmic and Proarrhythmic Actions /
title_full Antiarrhythmic Drugs [electronic resource] : Mechanisms of Antiarrhythmic and Proarrhythmic Actions /
title_fullStr Antiarrhythmic Drugs [electronic resource] : Mechanisms of Antiarrhythmic and Proarrhythmic Actions /
title_full_unstemmed Antiarrhythmic Drugs [electronic resource] : Mechanisms of Antiarrhythmic and Proarrhythmic Actions /
title_sort antiarrhythmic drugs [electronic resource] : mechanisms of antiarrhythmic and proarrhythmic actions /
publisher Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer,
publishDate 1995
url http://dx.doi.org/10.1007/978-3-642-85624-2
work_keys_str_mv AT breithardtguntereditor antiarrhythmicdrugselectronicresourcemechanismsofantiarrhythmicandproarrhythmicactions
AT borggrefemartineditor antiarrhythmicdrugselectronicresourcemechanismsofantiarrhythmicandproarrhythmicactions
AT cammajohneditor antiarrhythmicdrugselectronicresourcemechanismsofantiarrhythmicandproarrhythmicactions
AT shenasamohammadeditor antiarrhythmicdrugselectronicresourcemechanismsofantiarrhythmicandproarrhythmicactions
AT haverkampwilhelmeditor antiarrhythmicdrugselectronicresourcemechanismsofantiarrhythmicandproarrhythmicactions
AT hindricksgerhardeditor antiarrhythmicdrugselectronicresourcemechanismsofantiarrhythmicandproarrhythmicactions
AT springerlinkonlineservice antiarrhythmicdrugselectronicresourcemechanismsofantiarrhythmicandproarrhythmicactions
_version_ 1756271637235236864
spelling KOHA-OAI-TEST:2312262018-07-31T00:13:45ZAntiarrhythmic Drugs [electronic resource] : Mechanisms of Antiarrhythmic and Proarrhythmic Actions / Breithardt, Günter. editor. Borggrefe, Martin. editor. Camm, A. John. editor. Shenasa, Mohammad. editor. Haverkamp, Wilhelm. editor. Hindricks, Gerhard. editor. SpringerLink (Online service) textBerlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer,1995.engManagement and prevention of tachyarrhythmias, especially of serious ventricular arrhythmias after myocardial infarction, is still a major problem. Large-scale evidence suggests an increased harm induced by antiarrhythmic drugs in the presence of organic heart disease although they effectively suppress spontaneous arrhythmias. This increased risk has been linked to their proarrhythmic potential and to possible interactions by ischaemia. However, the mechanisms by which antiarrhythmic drugs exert their antiarrhythmic and proarrhythmic actions are still poorly understood. Therefore, it was a time to present an update on the mechanisms of antiarrhythmic and proarrhythmic action of drugs which act on the electrophysiological properties of the heart. World renowned electrophysiologists as well as clinicians have joint to address important topics which range from the effect of antiarrhythmic drugs on single channels and on arrhythmia models to the clinical arena.Basic Mechanisms of Antiarrhythmic Drug Action -- Sodium Channel Blockade as an Antiarrhythmic Mechanism -- Pharmacology of T and L type Ca2+ Channels in Cardiac Tissue -- Molecular Biology and Ion Channel Biophysics: Their Role in Rational Pharmacological Antiarrhythmic Therapy -- Selective Pharmacological Modification of Repolarizing Currents: Antiarrhythmic and Proarrhythmic Actions of Agents that Influence Repolarization of the Heart -- A Shift from Class to Class III Drugs in the Medical Treatment of Arrhythmias: Wishful Thinking? -- Use Dependence and Reverse Use Dependence of Antiarrhythmic Agents: Pro-and Antiarrhythmic Actions -- Modulation of Antiarrhythmic Drug Action by Disease and Injury -- Interaction of Transient Ischemia with Antiarrhythmic Drugs -- Management of Patients with Sustained Ventricular Tachyarrhythmias: Differnt Clinical Studies, Different Patients -- Antiarrhythmic Drug Action: Modulation by Disease and Injury -- Reentrant Excitation: Pharmacological Interactions -- Pharmacological Modulation of Reentrant Excitation in Experimental Models -- Reentry in Clinical Arrhythmias: Mechanisms Responsible for Antiarrhythmic Drug Efficacy -- Variability of the Arrhythmogenic Substrate: Drug Influences -- Experimental Models for the Assessment of Antiarrhythmic and Proarrhythmic Drug Action: Traditional and Newer Models -- Influence of the Autonomic Nervous System on the Action of Antiarrhythmic Drugs -- Role of Drugs in Torsade de Pointes and Triggered Activity -- The Study of Pharmacokinetics and Pharmacodynamics as a Tool for Understanding Mechanisms of Antiarrhythmic Drug Action -- Electrophysiologic Effects, Clinical Efficacy and Antiarrhythmic and Proarrhythmic Effects of Sodium Channel Blockers in Patients with Ventricular Tachyarrhythmias -- Antiarrhythmic Versus Proarrhythmic Effects of Class III Agents -- “Novel” Antiarrhythmic Drugs -- Electrophysiologic Properties and Antiarrhythmic Effects of Adenosine and Adenosine Triphosphate -- Magnesium-Electrophysiological Effects, Antiarrhythmic Properties and Clinical Applications -- Future Perspectives -- The Classification of Antiarrhythmic Drugs: How do we Educate the Scientist and the Clinician?.Management and prevention of tachyarrhythmias, especially of serious ventricular arrhythmias after myocardial infarction, is still a major problem. Large-scale evidence suggests an increased harm induced by antiarrhythmic drugs in the presence of organic heart disease although they effectively suppress spontaneous arrhythmias. This increased risk has been linked to their proarrhythmic potential and to possible interactions by ischaemia. However, the mechanisms by which antiarrhythmic drugs exert their antiarrhythmic and proarrhythmic actions are still poorly understood. Therefore, it was a time to present an update on the mechanisms of antiarrhythmic and proarrhythmic action of drugs which act on the electrophysiological properties of the heart. World renowned electrophysiologists as well as clinicians have joint to address important topics which range from the effect of antiarrhythmic drugs on single channels and on arrhythmia models to the clinical arena.Medicine.Pharmacology.Cardiology.Medicine & Public Health.Cardiology.Pharmacology/Toxicology.Springer eBookshttp://dx.doi.org/10.1007/978-3-642-85624-2URN:ISBN:9783642856242